Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
3(25%)
Results Posted
20%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
10
83%
Ph early_phase_1
1
8%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 1Safety & dosage
1(8.3%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(4)
Completed(5)
Terminated(1)
Other(2)

Detailed Status

Completed5
Recruiting3
unknown2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
83.3%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (8.3%)
Phase 11 (8.3%)
N/A10 (83.3%)

Trials by Status

unknown217%
completed542%
recruiting325%
not_yet_recruiting18%
terminated18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12